From 2000-2009 he was Editor-in-Chief of the Journal of Substance Abuse Treatment. From 2009 to 2011, he was Deputy Director of the White House Office of National Drug Control Policy (ONDCP) where he formulated President Obama’s National Drug Control Strategy and helped include addiction treatment into the Affordable Care Act. In 2015-2016 he served as Senior Editor on the US Surgeon General’s Report, Facing Addiction.
In his career he has published over 550 articles and chapters on addiction research and was awarded over 150 NIH research grants. He has been among the top ten most cited researchers in the addiction field for 15 years.
Dr. McLellan is the recipient of several distinguished awards including the Lifetime Achievement Awards of the American, Italian, Australian, Egyptian and British Societies of Addiction Medicine; the Robert Wood Johnson Innovator Award; Distinguished Contribution to Addiction Medicine from the American Public Health Association, the American Medical Association; and jointly from the National Institutes of Drug Abuse and Alcoholism and Alcohol Abuse.
He currently serves on the boards of Indivior LLC (makers of Suboxone) and Recover Together; and lives with his wife Kerry in Sarasota Florida.
Pre-Addiction - A Missing Concept for Treating Substance Use Disorder, Aug 2022
Libby Jones is the Program Director of Global Health Advocacy Incubator, GHAI’s Overdose Prevention Initiative. Libby leads the Initiative’s advocacy efforts, advancing federal policies...
The question posed to High Truths and Dr. Lev is “why do people use drugs?” To answer this question Dr. Lev interviews Robert, a...
Drug Cartels vs Criminal Organizations - who is responsible for fentanyl flooding and killing Americans? Join Luis Chaparro, investigative journalist for an inside scoop...
